# Syncona Limited (SYNC.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Healthcare. Price 112p, market value 683 millionp.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Syncona Limited reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.07**. A PEG of 0.07 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 18.3×**. Each dollar of revenue is priced at 18.3×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 0.2×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.
- **Free-cash-flow yield: 6.4%** (5-yr avg 0.0%). Free cash flow equals 6.4% of the market value, above its five-year average of 0.0%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.

## Profitability
- **Gross margin: 100.0%**. Syncona Limited keeps 100.0% of revenue after the direct cost of what it sells, the kind of margin that comes with software, brands or pricing power.
- **Operating margin: -345.0%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -15.4%**. The company reported a net loss over the last twelve months.
- **Return on equity: -0.8%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -12.5%**. Return on all capital, debt included, is -12.5%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -14.4%**. Each dollar of assets produces -14.4% of profit.

## Growth
- **Revenue growth (1 yr): 183.9%** (5-yr -6.1%/yr). Revenue grew 183.9% over the last year, against -6.1% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 93.4%**. Earnings per share rose 93.4%, slower than revenue, so margins compressed.

## Financial health
- **Debt to equity: 0.00**. Debt is 0.00 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.0×**. It would take 0.0 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 3.51** (quick 3.51). Current assets cover the next year's liabilities 3.51 times.
- **Altman Z-score: 29.01**. A Z-score of 29.01 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 7/9**. 7 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend: none**. Syncona Limited does not currently pay a dividend, but it returned 7.3% of its market value through buybacks over the last year.

## Price and momentum
- **Total return (1 yr): 19.7%** (YTD 19.5%, 3-mo 15.6%). The shares are up 19.7% over twelve months including dividends.
- **From 52-week high: -4.1%** (29.3% above the low). Trading within 5% of its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 64**. An RSI of 64 is neutral.
- **Beta (1 yr): 0.09** (volatility 19%). Beta of 0.09 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SYNC.L · Page: https://foliofundamentals.com/stocks/sync.l

Not investment advice.